These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26383000)

  • 1. Targeting the interleukin pathway in the treatment of asthma.
    Chung KF
    Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatments for severe treatment-resistant asthma: targeting the right patient.
    Chung KF
    Lancet Respir Med; 2013 Oct; 1(8):639-652. PubMed ID: 24461667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies for the treatment of refractory asthma.
    Hambly N; Nair P
    Curr Opin Pulm Med; 2014 Jan; 20(1):87-94. PubMed ID: 24275927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
    Shimizu Y; Dobashi K; Fueki N; Fueki M; Okada T; Tomioka S; Makino S; Mori M
    J Biol Regul Homeost Agents; 2011; 25(2):177-86. PubMed ID: 21880206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New drugs for severe asthma].
    Sattler C; Malrin R; Garcia G; Humbert M
    Presse Med; 2016 Nov; 45(11):1043-1055. PubMed ID: 27836376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S; Yanagihara Y
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and cytokine-specific therapy in asthma.
    Desai D; Brightling C
    Adv Clin Chem; 2012; 57():57-97. PubMed ID: 22870587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic therapy in asthma: entering the new age of personalized medicine.
    Fajt ML; Wenzel SE
    J Asthma; 2014 Sep; 51(7):669-76. PubMed ID: 24712500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
    Bagnasco D; Ferrando M; Varricchi G; Passalacqua G; Canonica GW
    Int Arch Allergy Immunol; 2016; 170(2):122-31. PubMed ID: 27637004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Therapy for Severe Asthma: Identifying the Right Patients.
    Low K; Bardin PG
    Mol Diagn Ther; 2017 Jun; 21(3):235-247. PubMed ID: 28044257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future biologic therapies in asthma.
    Quirce S; Bobolea I; Domínguez-Ortega J; Barranco P
    Arch Bronconeumol; 2014 Aug; 50(8):355-61. PubMed ID: 24685200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-IgE therapy in persistent allergic asthma].
    Skiepko R; Zietkowski Z; Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A
    Przegl Lek; 2009; 66(3):141-4. PubMed ID: 19689039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th2 cytokine antagonists: potential treatments for severe asthma.
    Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS
    Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil apoptosis as a therapeutic target in allergic asthma.
    Ilmarinen P; Kankaanranta H
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):109-17. PubMed ID: 24148899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.